Editor's ChoiceMain Category: Regulatory Affairs / Drug Approvals
Also Included In: Breast Cancer
Article Date: 24 Feb 2011 - 10:00 PST
email to a friend printer friendly opinions
<!-- rate article
Patient / Public:
4 (1 votes)Healthcare Prof:
The United Kingdom's regulatory board, has rejected Avastin (bevacizumab) for the treatment of patients suffering from metastatic breast cancer. There is simply not enough proof that the drug is truly beneficial in
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment